Nom du produit:3-(3-methylcyclobutyl)-3H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-c]pyridine

IUPAC Name:3-(3-methylcyclobutyl)-3H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-c]pyridine

CAS:1858938-08-5
Formule moléculaire:C10H16N4
Pureté:95%+
Numéro de catalogue:CM408261
Poids moléculaire:192.27

Unité d'emballage Stock disponible Prix($) Quantité
CM408261-100mg 4-5 Weeks ǯŢƞ
CM408261-250mg 5-6 Weeks ĽĽȀȀ
CM408261-500mg 5-6 Weeks ĽǯƞƄ
CM408261-1g 6-7 Weeks ȎưȀź

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1858938-08-5
Formule moléculaire:C10H16N4
Point de fusion:-
Code SMILES:CC1CC(C1)N1N=NC2=C1CNCC2
Densité:
Numéro de catalogue:CM408261
Poids moléculaire:192.27
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.